Business · 14/05/1998
FDA Releases Guidance for Submitting and Reviewing Complete Responses to Clinical Holds
The Food and Drug Administration (FDA) has made available a new guidance document that outlines the process for submitting and reviewing complete responses to clinical holds on investigational new drug applications
Original source language: Federal Register — Food and Drug AdministrationOpen original release →